ATTENUBIOTICS Trademark

Trademark Overview


On Friday, November 6, 2020, a trademark application was filed for ATTENUBIOTICS with the United States Patent and Trademark Office. The USPTO has given the ATTENUBIOTICS trademark a serial number of 90304009. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, September 17, 2025. This trademark is owned by Attenubiotics Inc.. The ATTENUBIOTICS trademark is filed in the Pharmaceutical Products and Natural Agricultural Products categories with the following description:

Nutritional supplements for general health and well-being; nutritional supplements for animal foodstuffs; animal feed additives for use as nutritional supplements; animal feed supplements; Pharmaceutical preparations for the prevention and treatment of pathogenic infections in humans and animals caused by pathogenic agents in humans and animals, namely preparations for inhibiting the production or bioavailability of adenosine triphosphate (ATP) required for replication of the pathogenic agents to provide the host organism the time to mount an effective immune response to the pathogenic agents without being overwhelmed with exponential pathogenic replication of the pathogenic agents; Pharmaceutical preparations for the prevention and treatment of pathogenic infections, namely pharmaceutical preparations for attenuation of pathogen replication cycles in humans and animals; Pharmaceutical preparations for the prevention and treatment of pathogenic infections in humans and animals, namely ...

Animal feed
attenubiotics

General Information


Serial Number90304009
Word MarkATTENUBIOTICS
Filing DateFriday, November 6, 2020
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateWednesday, September 17, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 30, 2021

Trademark Statements


Goods and ServicesNutritional supplements for general health and well-being; nutritional supplements for animal foodstuffs; animal feed additives for use as nutritional supplements; animal feed supplements; Pharmaceutical preparations for the prevention and treatment of pathogenic infections in humans and animals caused by pathogenic agents in humans and animals, namely preparations for inhibiting the production or bioavailability of adenosine triphosphate (ATP) required for replication of the pathogenic agents to provide the host organism the time to mount an effective immune response to the pathogenic agents without being overwhelmed with exponential pathogenic replication of the pathogenic agents; Pharmaceutical preparations for the prevention and treatment of pathogenic infections, namely pharmaceutical preparations for attenuation of pathogen replication cycles in humans and animals; Pharmaceutical preparations for the prevention and treatment of pathogenic infections in humans and animals, namely pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for the prevention and treatment of pathogenic infections in humans and animals, namely pharmaceutical preparations for regulating the immune system, pharmaceutical preparations for the prevention and treatment of respiratory disorders, anti-viral agents, pharmaceutical preparations for the prevention and treatment of cancer, pharmaceutical preparations for the prevention and treatment of diabetes, pharmaceutical preparations for the prevention and treatment of degenerative nerve diseases and disorders, namely, dementia, Alzheimer's disease, Parkinson's disease, Huntington's disease and multiple sclerosis, pharmaceutical preparations for the prevention and treatment of gastrointestinal diseases, pharmaceutical preparations for the prevention and treatment of cardiovascular diseases, pharmaceutical preparations for the prevention and treatment of inflammatory muscle diseases and disorders; pharmaceutical preparations for the prevention and treatment of pathogenic infections in humans and animals, namely pharmaceutical preparations for attenuation of pathogen replication cycles in humans and animals
Goods and ServicesAnimal feed

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 7, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class031 - Agricultural, horticultural and forestry products and grains not included in other classes; live animals; fresh fruits and vegetables; seeds, natural plants and flowers; foodstuffs for animals; malt.
US Class Codes001, 046
Class Status Code6 - Active
Class Status DateThursday, October 21, 2021
Primary Code031
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAttenubiotics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCalgary, Alberta T3K4C1
CA

Party NameAttenubiotics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCalgary, Alberta T2P3Y6
CA

Trademark Events


Event DateEvent Description
Tuesday, November 10, 2020NEW APPLICATION ENTERED
Thursday, January 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 13, 2021ASSIGNED TO EXAMINER
Tuesday, April 20, 2021PRIORITY ACTION WRITTEN
Tuesday, April 20, 2021PRIORITY ACTION E-MAILED
Tuesday, April 20, 2021NOTIFICATION OF PRIORITY ACTION E-MAILED
Wednesday, October 20, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 20, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 21, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, October 23, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 30, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 30, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 25, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, July 15, 2022SOU TEAS EXTENSION RECEIVED
Friday, July 15, 2022SOU EXTENSION 1 FILED
Friday, July 15, 2022SOU EXTENSION 1 GRANTED
Tuesday, July 19, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 19, 2023SOU TEAS EXTENSION RECEIVED
Thursday, January 19, 2023SOU EXTENSION 2 FILED
Thursday, January 19, 2023SOU EXTENSION 2 GRANTED
Saturday, January 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 24, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 24, 2023SOU TEAS EXTENSION RECEIVED
Monday, July 24, 2023SOU EXTENSION 3 FILED
Monday, July 24, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 24, 2023TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Monday, July 24, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 24, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, August 1, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 1, 2023SOU EXTENSION 3 GRANTED
Wednesday, August 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 16, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 17, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 17, 2024SOU EXTENSION 4 FILED
Wednesday, January 17, 2024SOU EXTENSION 4 GRANTED
Friday, January 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 23, 2025TEAS PETITION TO AMEND BASIS RECEIVED
Thursday, November 16, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 16, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 19, 2024SOU TEAS EXTENSION RECEIVED
Friday, July 19, 2024SOU EXTENSION 5 GRANTED
Friday, July 19, 2024SOU EXTENSION 5 FILED
Wednesday, July 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, January 25, 2025NOTICE OF ALLOWANCE CANCELLED
Wednesday, March 5, 2025ASSIGNED TO PETITION STAFF
Thursday, March 6, 2025PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Monday, March 17, 2025PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, March 17, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 6, 2025CASE RETURNED TO EXAMINATION
Monday, March 17, 2025NON-FINAL ACTION E-MAILED
Monday, March 17, 2025NON-FINAL ACTION WRITTEN
Monday, June 16, 2025APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, September 17, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 17, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 17, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 16, 2025APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED